Phase II trial of neoadjuvant weekly nanoparticle albumin-bound paclitaxel, carboplatin, and biweekly bevacizumab therapy in women with clinical stage ii or iii her2-negative breast cancer

Ewa Mrózek, Rachel Layman, Bhuvaneswari Ramaswamy, Maryam Lustberg, Andrea Vecchione, Michael V. Knopp, Charles L. Shapiro

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of neoadjuvant weekly nanoparticle albumin-bound paclitaxel, carboplatin, and biweekly bevacizumab therapy in women with clinical stage ii or iii her2-negative breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences